Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Gene Expression Modulation Broad transcriptomic analyses using Illumina microarray studies have characterized GHK-Cu as modulating the expression of approximately 4,000 human genes
It has been studied for its potential role in nerve regeneration and brain recovery following injuries like traumatic brain injury (TBI) or stroke
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
GHK-Cu (glycyl-histidyl-lysine copper, also called Copper Tripeptide-1) occurs naturally in your body
US$ 24.22
US$ 23.82
US$ 24.52
US$ 25.45
US$ 21.73
US$ 20.71
US$ 24.53
US$ 29.41
US$ 25.91
US$ 29.05
US$ 28.43
US$ 25.80
US$ 24.82
US$ 23.18
US$ 24.39